ID   PUTKO
AC   CVCL_2697
SY   Putko; PUTKO-1
DR   CLO; CLO_0008524
DR   CLDB; cl3960
DR   ECACC; 88042802
DR   Wikidata; Q54948707
RX   PubMed=3930277;
RX   PubMed=6245297;
RX   PubMed=6278188;
RX   PubMed=6811418;
CC   Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZI12 ! PUT
HI   CVCL_0004 ! K-562
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 8
//
RX   PubMed=3930277;
RA   Garson D., Dokhelar M.-C., Wakasugi H., Mishal Z., Tursz T.;
RT   "HLA class-I and class-II antigen expression by human leukemic K562
RT   cells and by Burkitt-K562 hybrids: modulation by differentiation
RT   inducers and interferon.";
RL   Exp. Hematol. 13:885-890(1985).
//
RX   PubMed=6245297; DOI=10.1093/jnci/64.4.725;
RA   Klein G., Zeuthen J., Eriksson I., Terasaki P.I., Bernoco M., Rosen A.,
RA   Masucci G., Povey S., Ber R.;
RT   "Hybridization of a myeloid leukemia-derived human cell line (K562)
RT   with a human Burkitt's lymphoma line (P3HR-1).";
RL   J. Natl. Cancer Inst. 64:725-738(1980).
//
RX   PubMed=6278188; DOI=10.1093/jnci/68.2.197;
RA   Klein G., Zeuthen J., Ber R., Ernberg I.;
RT   "Human lymphoma-lymphoma hybrids and lymphoma-leukemia hybrids. II.
RT   Epstein-Barr virus induction patterns.";
RL   J. Natl. Cancer Inst. 68:197-202(1982).
//
RX   PubMed=6811418; DOI=10.1016/S0171-2985(11)80031-8;
RA   Spira G., Koide N., Aman P., Ber R., Klein G.;
RT   "Truncated mu chain in a Burkitt lymphoma line (P3HR-1) and its fate
RT   in various hemapoietic somatic cell hybrids.";
RL   Immunobiology 162:199-209(1982).
//